Main Article Content
Background: Previous studies have demonstrated higher referral rates for invasive procedures among patients admitted with acute coronary syndromes (ACS) to hospitals with catheterization facilities compared to those without. Studies have also reported underuse of evidence-based medical therapies and cardiac rehabilitation programs post myocardial infarction. We evaluated referral patterns for cardiac catheterization and use of secondary prevention strategies in current practice.
Methods: We conducted a retrospective study of 397 patients with non-ST segment elevation ACS, comparing angiography referrals at a hospital with on-site catheterization facilities (Site A, n = 194) versus a hospital without (Site B, n = 203). We also recorded the use of secondary prevention strategies including discharge medications, referrals to smoking cessation programs and cardiac rehabilitation.
Results: There was no significant effect of on-site angiography on the decision to manage patients invasively (adjusted OR for on-site angiography 1.49 95% CI 0.92-2.44, p = .11), or wait times for cardiac catheterization (Site A 1.9 days vs. Site B 2.2 days, difference −0.3 days, 95% CI −0.83 to 0.55, p = .70). However, at the time of hospital discharge, less than 70% of patients were prescribed dual antiplatelet therapy and only 13% of patients were referred for cardiac rehabilitation.
Conclusion: These observations suggest that in contemporary practice in a Southern Ontario community, the availability of on-site percutaneous coronary intervention does not influence referral rates or wait times for cardiac catheterization. However we did observe significant underuse of cardiac rehabilitation programs and certain medical therapies. This suggests that despite improvements in access to invasive procedures, there remain important gaps in secondary prevention of coronary artery disease, which represent opportunities to improve quality of care in these patients.
2. Antman E, Cohen M, Bernink P, et al. The TIMI risk score for unstable angina/Non-ST elevation MI. JAMA 2000;284(7):835–42.
3. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507–14.
4. Alter DA, Naylor D, Austic PC, Chan BJ, Tu JV. Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ 2003;168 (3):261–4.
5. Singh N, Gupta M, Fell D, Gangbar E. Impact and inequity of inpatient waiting times for advanced cardiovascular services in community hospitals across the Greater Toronto Area. Can J Cardiol 1999;15(7):777–82.
6. Lee CH, Tan M, Yan AT, et al. Use of cardiac catheterization for non–STsegment elevation acute coronary syndromes according to initial risk. Arch Intern Med 2002;169:291–96.
7. Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994 – 2005. JAMA 2010;303(18):1841–47.
8. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J 2003;145:438–44.
9. Tu JV, Donovan LR, Wang DS, et al. Effectiveness of Public Report Cards for Improving Quality of Care (The EFFECT study: a Randomized Trial). JAMA 2009;302(21):2330–37.
10. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345 (7):494–502.
11. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011. Jul 6; (7):CD001800.
12. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post myocardial infarction: a systematic review and metaanalysis of randomized controlled trials. Am Heart J 2011;162(4):571–84.